Cat. No. | Product name | CAS No. |
DCC4924 |
St-2262
Novel selective NaV1.7 inhibitor, blocking the extracellular vestibule of the channel with an IC50 of 72 nM and greater than 200-fold selectivity over off-target sodium channel isoforms, NaV1.1-1.6 and NaV1.8 |
|
DCC4925 |
St4070
Highly selective FAAH>fatty acid amide hydrolase (FAAH) inhibitor |
1186236-75-8 |
DCC4926 |
St7710aa1
Novel PARP-1 inhibitor, showing significant in vitro target inhibition and capability to substantially bypass the multidrug resistance mediated by Pgp |
1542067-20-8 |
DCC4927 |
Sta-9584
Novel tubulin-binding vascular disrupting agent (VDA) |
906481-23-0 |
DCC4928 |
Stad-2
Cell permeable AKAP disruptor, selectively binding to PKA-RII and blocking the interaction of PKA-RI with AKAP |
1542100-77-5 |
DCC4929 |
Stalobacin I
Novel Lipopeptide Antibiotic with Potent Antibacterial Activity against Multidrug-Resistant Bacteria |
|
DCC4930 |
Stanozolol [10418-03-8]
Anabolic-androgenic steroid (AAS), acting as an agonist of the androgen receptor (AR) |
10418-03-8 |
DCC4931 |
Stat3 -in-11
Novel STAT3 inhibitor, selectively inhibiting STAT3 phosphorylation and exhibiting potent antitumor activity |
|
DCC4932 |
stat3 Inhibitor 6
Novel inhibitor of STAT3 signaling pathway |
665014-97-1 |
DCC4933 |
Stat3-in-13r
Novel inhibitor of STAT3, targeting SH2 domain |
|
DCC4934 |
Stat3-in-3
Novel potent and selective inhibitor of STAT3 |
2361304-26-7 |
DCC4935 |
Stat3-in-a69
Novel inhibitor targeting the DNA-binding domain of STAT3, suppressing tumor growth, metastasis and STAT3 target gene expression in vivo |
1164546-70-6 |
DCC4936 |
Stat3-in-b9
Novel inhibitor of signal transducer and activator of transcription 3 (STAT3), inhibiting the proliferation of tumor cells harboring abnormal activation of STAT3, such as, MDA-MB-468, MDA-MB-231 and DU145 |
825611-06-1 |
DCC4937 |
Stat5a-in-27
Novel cell-permeable selective STAT5a inhibitor prodrug, inhibiting tyrosine phosphorylation of STAT5a with selectivity over STAT5b in cultured human leukemia cells, and representing a valuable tool to define the non-redundant molecular functions of the t |
|
DCC4938 |
Stat5b-in-6a
Highly Potent and Selective Inhibitor of the Transcription Factor STAT5b |
|
DCC4939 |
Stemazole
Novel human stem/progenitor cells proliferation activator, promoting survival and preserving stemness in human embryonic stem cells |
317337-07-8 |
DCC4940 |
Sterigmatocystin
Natural inducer of G1 arrest in primary human esophageal epithelial cells but G2 arrest in immortalized cells |
10048-13-2 |
DCC4941 |
Stf-038533
Novel inhibitor of expression from canonical CREB response element-containing promoters |
423744-59-6 |
DCC4942 |
Stg -001
Novel RBP4 antagonist for treatment of Stargardt disease |
|
DCC4943 |
Stictic Acid
Natural anti-feline infectious peritonitis virus (FIPV) agent, specifically targeting the 3CLpro of FIPV and inhibiting its replication |
549-06-4 |
DCC4944 |
Sting Agonist 11
Novel non-nucleotide STING agonist, demonstrating antitumor activity when dosed intratumorally in a syngeneic mouse model |
|
DCC4945 |
Sting Inhibitor C-171
Novel covalent antagonist of hsSTING |